MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$5,000,000
EPS
-$1.33
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
2,953,000 -960,000* 2,789,000 -
General, administrative and other
2,115,000 4,175,000* 2,249,000 -
Total operating expenses
5,068,000 3,215,000 5,038,000 -
Loss from operations
-5,068,000 -3,215,000* -5,038,000 -
Change in fair value of warrant liability
-0* -0
Change in fair value of forward contract liability
-0* --
Change in fair value of sepa put option liability
54,000 253,000* 33,000 -
Change in fair value of convertible debt
0 765,000* -846,000 -
Commitment fee expenses
-0* -0
Placement agent and tail fee expenses
-0* --
Other expense
-2,000 -619,000* 0 0
Gain on termination of warrant and commitment fee liabilities
-0* --
Interest income
20,000 28,000* 73,000 -
Interest expense
4,000 204,000* 0 0
Total other income/(expense)
68,000 223,000* -740,000 -
Net loss
-5,000,000 -2,992,000 -5,778,000 -4,658,000
Net income (loss) attributable to common stockholders
----4,658,000
Basic EPS
-1.33 -0.057 -0.13 -0.12
Diluted EPS
-1.33 -0.057 -0.13 -0.12
Basic Average Shares
3,772,930 52,273,748 43,072,542 38,635,264
Diluted Average Shares
3,772,930 52,273,748 43,072,542 38,635,264
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Change in fair value ofsepa put option...$54,000 Interest income$20,000 Net loss-$5,000,000 Total otherincome/(expense)$68,000 Interest expense$4,000 Other expense-$2,000 Loss from operations-$5,068,000 Total operatingexpenses$5,068,000 Research and development$2,953,000 General, administrativeand other$2,115,000

FibroBiologics, Inc. (FBLG)

FibroBiologics, Inc. (FBLG)